Multiple Endocrine Neoplasia Type 2a
Also known as: Multiple endocrine neoplasia [MEN] type IIA / Multiple endocrine neoplasia type 2A (disorder) / Multiple endocrine neoplasia Type IIA / Multiple endocrine adenomatosis Type IIa / Multiple endocrine neoplasia, type 2 (disorder) / Multiple endocrine neoplasia Type 2 / Multiple endocrine neoplasia Type II / MEN Type II / Multiple endocrine adenomatosis Type II / MEA Type II
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01101 | Capecitabine | 1 | Withdrawn | 1 |
DB00853 | Temozolomide | 1 | Withdrawn | 1 |
DB07232 | Veliparib | 1 | Withdrawn | 1 |
DB05294 | Vandetanib | 1 / 2 | Completed | 1 |
DB00398 | Sorafenib | 2 | Completed | 1 |